Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 2/20 | 0.76 |
| ▸ | MAPT | P10636 | 2/20 | 0.76 |
| ▸ | MEN1 | O00255 | 2/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.76 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.76 |
| ▸ | NSD2 | O96028 | 1/20 | 0.76 |
| ▸ | TP53 | P04637 | 1/20 | 0.76 |
| ▸ | POLB | P06746 | 1/20 | 0.76 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.76 |
| ▸ | GAA | P10253 | 1/20 | 0.76 |
| ▸ | THRB | P10828 | 1/20 | 0.76 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.76 |
| ▸ | PKM | P14618 | 1/20 | 0.76 |
| ▸ | IDO1 | P14902 | 1/20 | 0.76 |
| ▸ | HPGD | P15428 | 1/20 | 0.76 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.76 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.76 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Purpurogallin SCHEMBL33853 | 0.87 | CDK2 (1.00) | CDK2MAPTMEN1ALDH1A1KMT2A | |
| Purpurogallin SCHEMBL29481120 | 0.87 | CDK2 (1.00) | CDK2MAPTMEN1ALDH1A1KMT2A | |
| Purpurogallin SCHEMBL2839450 | 0.84 | CDK2 (0.93) | CDK2MAPTMEN1ALDH1A1KMT2A | |
| Purpurogallin SCHEMBL15560816 | 0.83 | CDK2 (0.83) | CDK2MAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL17071994 | 0.81 | MEN1 (0.59) | CDK2MAPTMEN1ALDH1A1KMT2A | |
| Purpurogallin SCHEMBL28319789 | 0.76 | MEN1 (0.76) | CDK2MAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL24107152 | 0.76 | CDK2 (0.71) | CDK2MAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL15557274 | 0.76 | CDK2 (0.77) | CDK2MAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL12610186 | 0.76 | CDK2 (0.71) | CDK2MAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL17357502 | 0.76 | ALDH1A1 (0.71) | CDK2MAPTMEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023085323-A1 | METHOD FOR REDUCING MEASUREMENT ERRORS DUE TO HEMOLYZED HEMOGLOBIN | 東洋紡株式会社 | 2023-05-19 | — | — | WO | disclosed |
| US-11384381-B2 | Reaction accelerating agent | KIKKOMAN CORPORATION (JP) | 2022-07-12 | — | — | US | disclosed |
| US-11208675-B2 | Reaction accelerating agent | KIKKOMAN CORPORATION (JP) | 2021-12-28 | — | — | US | disclosed |
| WO-2019216408-A1 | METHOD FOR SUPPRESSING REDUCTIONS IN BIOLOGICAL COMPONENT MEASUREMENT REAGENT KIT SENSITIVITY | 東洋紡株式会社 (JP) | 2019-11-14 | — | — | WO | disclosed |
| WO-2019216407-A1 | METHOD FOR SUPPRESSING DECREASE IN SENSITIVITY OF REAGENT KIT FOR MEASURING BIOLOGICAL COMPONENT | 東洋紡株式会社 (JP) | 2019-11-14 | — | — | WO | disclosed |
| WO-2019216406-A1 | METHOD FOR SUPPRESSING REDUCTIONS IN BIOLOGICAL COMPONENT MEASUREMENT REAGENT KIT SENSITIVITY | 東洋紡株式会社 (JP) | 2019-11-14 | — | — | WO | disclosed |
| WO-2019216405-A1 | METHOD FOR SUPPRESSING REDUCTION IN SENSITIVITY OF BIOLOGICAL-COMPONENT-MEASURING REAGENT KIT | 東洋紡株式会社 (JP) | 2019-11-14 | — | — | WO | disclosed |
| US-20190316174-A1 | REACTION ACCELERATING AGENT | KIKKOMAN CORPORATION (JP) | 2019-10-17 | — | — | US | disclosed |
| US-20190300929-A1 | REACTION ACCELERATING AGENT | KIKKOMAN CORPORATION (JP) | 2019-10-03 | — | — | US | disclosed |
| US-20110135787-A1 | DEODORIZING COMPOSITION USING PEROXIDASE UNDER NEUTRALITY | LOTTE CO. LTD. | 2011-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11384381-B2 | Reaction accelerating agent | MPO, AOX1, MAOA | CDK2 341/4885MAPT 4544/4885MEN1 3767/4885 |
| US-20190316174-A1 | REACTION ACCELERATING AGENT | MPO, AOX1, MAOA | CDK2 341/4885MAPT 4544/4885MEN1 3767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.